“…The capacity for recent biomedical HIV prevention approaches such as pre‐exposure prophylaxis (Anderson et al, ; CDC, ) and HIV treatment adherence (Attia, Egger, Müller, Zwahlen, & Low, ; Rodger et al, ) could be expanded if the target population most impacted by HIV is actively engaged in the development and implementation of these strategies (Magnus et al, ; Mayer et al, ). Studies have documented how medical mistrust among BMSM inhibits optimal participation in prevention behaviors, HIV treatment, and research (Cahill et al, ; Dale, Bogart, Wagner, Galvan, & Klein, ; Dangerfield II et al, ; Magnus et al, ; Mays, Cochran, & Zamudio, ). There has been an increased use of focus groups as a research method to elicit richer data and develop interventions for BMSM (Cahill et al, ; Dangerfield II et al, ; Harawa et al, ; Holloway et al, ; Hussen et al, ).…”